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Objective: Patients who have undergone prior mediastinal radiation might require coronary artery bypass graft-
ing. However, there is some concern regarding potential radiation damage to the internal thoracic artery. Our
objective was to assess the late patency of the internal thoracic artery and venous grafts in patients with prior
mediastinal radiation.
Methods: Patients undergoing coronary artery bypass grafting at our clinic after prior mediastinal radiation were
identified, andmedical records, including operative reports, clinical notes, and coronary angiography,were reviewed.
Results:Between 1985 and 2005, 138 patients had coronary artery bypass grafting after mediastinal radiation. Of
these, 25 underwent clinically indicated postoperative angiography. The mean patient age was 56.1 13.8 years,
and 24% were female. All patients received between 3000 and 6000 rads in fractionated doses. Seventy-two per-
cent of patients had 3-vessel coronary artery disease. At late angiography (mean, 2.2 years), 6 (32%) of 19 in-
ternal thoracic arteries and 13 (27%) of 48 venous or radial arterial conduits showed stenosis of 70% or
greater (P ¼ .72). Assessing only grafts that were anastomosed to the left anterior descending coronary artery,
35% (6 of 17) of internal thoracic artery grafts and 60% (3 of 5) of non–internal thoracic artery grafts showed
narrowing of 70% or greater (P ¼ .61). Among patients who received a graft to the left anterior descending cor-
onary artery (n¼ 113), however, age-adjusted survival at 5 years was superior among those receiving an internal
thoracic artery graft to the left anterior descending coronary artery.
Conclusions: Internal thoracic artery graft patency among patients with prior radiation was less than expected and
similar to that for venous grafts, although the effect of conduit disease versus distal target vessel runoff is
unknown. Despite this, late survival was superior among those receiving an internal thoracic artery graft to the
left anterior descending coronary artery. These data support use of an internal thoracic artery graft to the left
anterior descending coronary artery when it appears grossly to be an acceptable conduit.Patients who have undergone prior mediastinal radiation are
at risk for early development of coronary artery disease1 and
might require surgical revascularization. The preferred con-
duit for coronary artery bypass grafting (CABG), particu-
larly to the left anterior descending coronary artery (LAD),
is the internal thoracic artery (ITA); however, the effect of
therapeutic doses of radiation on the integrity of the ITA
itself is unknown. Studies regarding the late patency of
irradiated ITAs are small and conflicting.2-13 We therefore
retrospectively reviewed patients who had a history of medi-
astinal radiation and underwent CABG at our institution and
subsequent graft angiography.
MATERIALS AND METHODS
Patients
Institutional review board approval was obtained. Patients who received
large doses of radiation (3000–6000 rads) to the mediastinum before cardiac
operation were identified from institutional databases. Patients who received
only neck, spine, or tangential radiation for breast cancer were excluded. Be-
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mediastinal radiation and CABG. After review of clinical information from
the medical record, 25 (18%) patients underwent follow-up angiography. In
all cases angiography was performed for clinical indications, including
chest pain or shortness of breath.
Surgical Approach
Although there is no policy at our institution regarding patients with me-
diastinal radiation therapy in general, the ITA is preferred as the conduit of
choice to the LAD. After median sternotomy, ITAs were harvested by using
a pedicled technique and grossly inspected for patency. If the ITA did not
appear to have adequate blood flow or was fibrotic, the artery was ligated,
and venous or radial arterial conduits were used as bypass conduits. It has
not been the practice in our institution to assess the ITAs preoperatively
for patency during coronary artery catheterization. Intraoperative graft
flow measurements were not performed. At the time of the operation, con-
comitant procedures were performed as indicated.
Statistical Analysis
Continuous variables are expressed as means and standard deviations or
medians and ranges. Groups were compared by using t tests or c2 tests, as
appropriate. Vital status for all patients was attained through use of Accurint
(www.accurint.com) and the Social Security Death Index. Kaplan–Meier
survival curves were created with SAS version 9.1 (SAS Institute, Inc,
Cary, NC) and compared with a log-rank test.
RESULTS
Of the 138 patients undergoing CABG after mediastinal ra-
diation, 51% were female, and the mean age was 63  13ardiovascular Surgery c Volume 136, Number 5 1167
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years. The most common reasons for mediastinal radiation
included breast cancer (40%), lymphomas (including
Hodgkin’s and non-Hodgkin’s lymphoma: 34%), germ
cell tumors (9%), lung cancers (8%), and others (thymic,
esophageal, and laryngeal: 9%).
Patients With Follow-up Angiography
Of the 25 patients who had follow-up angiography,
a lower percentage were female (24%), and the patients
were younger when compared with the entire cohort (Table
1). The most common reasons for radiation therapy were
similar (52% lymphoma, 24% germ cell cancer, and 20%
breast cancer). The median time from radiation exposure
to CABG was 23.1 years (range, 2.1–40.3 years) for the
angiography group. Fifteen patients had a history of hyper-
tension, 17 patients had hyperlipidemia, 12 patients were
previous or current smokers, and 4 patients had diabetes
(Table 2). Twenty-one (84%) of the patients were in New
York Heart Association class III or IV, and the mean ejection
fraction was 56%  12%.
Among those patients undergoing postoperative angiog-
raphy, the majority (72%) had 3-vessel disease, and the av-
erage number of distal anastomoses per patient was 2.6
versus 2.4 (P ¼ .33) in those patients who did not have fol-
low-up angiography. Conduit selection was similar between
the angiography group and the whole group. Among the an-
giography group (n ¼ 25), there were 19 ITAs used (16 left
and 3 right), 2 radial arteries, and 46 vein grafts. Sixteen ITA
grafts and 5 vein grafts were anastomosed to the LAD. Con-
comitant procedures were performed in 9 patients, including
aortic valve replacement (n ¼ 6), mitral valve replacement
(n¼ 1), mitral valve repair (n¼ 1), pericardiectomy (n ¼ 1),
and septal myectomy (n¼ 1).
The median time from operation to angiography was 2.2
years (range, 0.5–10.3 years). Angiograms were performed
for clinical indications, including symptoms or positive non-
invasive test results. In the ITA grafts, 4 were completely oc-
cluded, leaving 15 (79%) of 19 patent. Of these, 9 ITA grafts
were perfectly patent, 4 had narrowing of less than 70%, and
2 were narrowed by 70% or more. Analysis of other con-
duits, both radial arteries and vein grafts, revealed that 13
grafts were completely occluded, resulting in 36 (73%) of
48 patent grafts. This included 12 that were perfectly patent,
19 that showed less than 70% stenosis, and 5 that showed
70% or greater stenosis. Late patency on angiography was
not significantly different between ITA grafts and venous1168 The Journal of Thoracic and Cardiovascular Sugrafts (P¼ .44). Assessing only grafts that were anastomosed
to the LAD, 32% of ITA grafts and 60% of the non-ITA
grafts showed stenosis of 70% or greater (P ¼ .61).
Patients With Grafts to the LAD
We selected all patients who had a graft to the LAD (n ¼
113, 82%). Patients did not receive an ITA graft to the LAD
(n ¼ 34) for several reasons: 10 were fibrotic or scarred, 4
were not used because the patient’s condition was unstable,
2 had prior injury to the ITA, 2 had a known ITA stenosis on
angiography, 1 had poor pulsations, 1 was of inadequate
length, and 1 had tumor-positive tissue around the ITA. In
13 patients there was inadequate documentation to deter-
mine the reason why the ITA was not used.
Late survival was compared between patients who had an
ITA graft (n ¼ 79) and those who had a venous graft (n ¼
34) to the LAD. At 1 and 5 years, the age-adjusted survivals
of patients with an ITA graft to the LADwere 89% and 67%
compared with 80% and 51% in patients with a venous graft
to the LAD, respectively (P ¼ .16, Figure 1). When all pa-
tients who received a graft to the LAD (n ¼ 113) were com-
pared with an age- and sex-matched population, the overall
survival was decreased (P< .001, Figure 2).
TABLE 1. Preoperative and operative characteristics of the entire
cohort of patients with prior mediastinal radiation
Patient characteristics
Patients with
follow-up
angiography
(n ¼ 25)
Patients
without
follow-up
angiography
(n ¼ 113) P value
Mean age (y) 56  13 64  13 .007
Female sex (%) 6 (24) 65 (58) .002
History of smoking (%) 12 (48) 61 (54) .588
History of diabetes (%) 4 (16) 24 (21) .556
History of
hypercholesterolemia (%)
17 (68) 74 (65) .810
History of hypertension 15 (52) 63 (58) .698
New York Heart Association
class III/IV (%)
21 (84) 88 (78) .288
Mean ejection fraction (%) 56  12 57  13 .212
Isolated bypass procedure (%) 17 (68) 63 (56) .262
Mean no. of distal
anastomoses
2.6  1.2 2.4  1.0 .333
ITA use (no. of patients,%) 18 (72) 65 (58)
Left ITA 15 59 .731
Right ITA 2 4 .298
Bilateral ITA 1 2 .454
Radial artery use (no. of
patients,%)
2 (8) 4 (4) .298
Venous distal anastomoses
1 4 27 .392
2 9 44 .237
3 8 26 .345
4 0 1 1.000
ITA, Internal thoracic artery.rgery c November 2008
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Patient no. Age at operation (y) M/F Year of radiation Cancer type [ BP Smoking Hx DM [ Lipids NYHA class
1 57 M 1968 Sarcoma No No No No 2
2 62 M 1986 Hodgkin’s No Yes No No 3
3 61 M 1986 Hodgkin’s No No Yes No 3
4 39 M 1980 Non-Hodgkin’s Yes No No No 3
5 71 F 1955 Breast (L) Yes No No No 3
6 76 F 1984 Breast (L) No No No Yes 4
7 39 M 1969 Hodgkin’s No No No Yes 3
8 45 M 1976 Hodgkin’s No No No No 2
9 48 M 1964 Hodgkin’s Yes Yes Yes Yes 2
10 49 M 1976 Germ cell Yes Yes No Yes 4
11 39 M 1974 Hodgkin’s Yes No No No 4
12 46 M 1967 Hodgkin’s No Yes No Yes 3
13 57 M 1986 Germ cell No Yes No Yes 3
14 47 M 1970 Hodgkin’s No Yes No Yes 4
15 67 F 1969 Breast (R) Yes No Yes Yes 3
16 37 M 1976 Hodgkin’s Yes Yes No Yes 3
17 58 M 1975 Germ cell Yes No No Yes 4
18 64 M 1967 Hodgkin’s Yes Yes No Yes 2
19 60 F 1960 Germ Cell Yes Yes No Mo 4
20 46 M 1970 Non-Hodgkin’s No No No Yes 4
21 89 F 1992 Breast (R) No No No Yes 3
22 53 M 1965 Non-Hodgkin’s No Yes No Yes 3
23 63 M 1963 Seminoma Yes No No Yes 4
24 76 F 2002 Breast (L) Yes Yes Yes Yes 4
25 62 M 1980 Seminoma Yes Yes No Yes 4
M, Male; F, female; BP, blood pressure; Hx, history; DM, diabetes mellitus; NYHA, New York Heart Association; L, left; R, right.DISCUSSION
Patients with prior mediastinal radiation can present with
myocardial, pericardial, valvular, and coronary artery dis-
ease. Radiation can cause damage to the vasculature through
direct damage to the endothelial cells.1 Fibrous proliferation
can then occur, resulting in a loss of parenchymal cells.2 In
patients who have medical conditions that also affect the
FIGURE 1. Age-adjusted survival compared between patients with prior
mediastinal radiation therapy who received an internal thoracic artery
(ITA) graft compared with a venous graft to the left anterior artery. This
age-adjusted comparison demonstrates superior survival in patients who re-
ceived an internal thoracic artery graft, but overall, it was not statistically
significant.The Journal of Thoracic and Cavascular system, such as hypertension or diabetes, radiation
damage to vessels can be greater in severity.2 When CABG
surgery is required, the choice of bypass conduit presents an
additional challenge. The ITA is the preferred conduit in
most circumstances, with 5-year patency rates in contempo-
rary series for nonirradiated ITA grafts as high as 96% to
98% in comparison with venous grafts as low as 83% to
FIGURE 2. Survival of patients who had prior mediastinal radiation ther-
apy and had either an internal thoracic artery or vein grafted to the left an-
terior descending coronary artery (LAD; n¼ 113). When compared with an
age- and sex-matched Minnesota population, patients who had prior medi-
astinal radiation therapy had a significantly reduced late survival.rdiovascular Surgery c Volume 136, Number 5 1169
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however, is uncertain.
Prior literature on the subject is divided. A study from
Nasso and colleagues3 suggested that irradiated skeletonized
ITAs have equal patency as saphenous veins and other arte-
rial conduits. Other authors have also supported the use of
the ITA in these patients with prior mediastinal radiation ex-
posure4-9; however, others have suggested that mediastinal
radiation might damage the ITA, causing either fragility or
leading to early graft failure if it is used as a conduit.10-13
Several of these studies10-12 are case reports, but in the study
by Hicks,13 the ITA was only usable as a graft in 3 of 14 pa-
tients with previous mediastinal radiation exposure because
of friability and fibrosis.
A previous study from our institution16 suggested that
because of the unknown quality of the ITA graft and the in-
creased risk of mediastinal wound complications in patients
with previous mediastinal radiation therapy, alternative con-
duits should be considered. Despite these concerns, because
of the well-documented effect of an ITA graft to the LAD on
late survival,17 it has been our strong institutional bias to use
the ITA conduit when possible. Indeed, in this series 79
(70%) of 113 patients with significant LAD disease received
an ITA graft. The argument to use the ITA is particularly
compelling because these patients are often young. Further-
more, with concerns about small-vessel disease and the ad-
equacy of distal runoff, the ITA is an appealing conduit.
This provided us with a sizeable population from which to
draw survival data. Unfortunately, only a small minority un-
derwent postoperative coronary angiography.
Preoperative assessment of the ITA might be a consider-
ation, although it has not been our practice up to now. Van
Son and coworkers4 and others6,7 suggest that if the patency
is ascertained preoperatively, the ITA can be safely used. In
general, patients in this study did not have examination of
the ITA on angiography before surgical revascularization
unless subclavian steal was suspected. All ITA grafts were
grossly inspected at time of surgical intervention for
patency.
In this study, graft patency after CABG in patients with
prior mediastinal radiation therapy was lower than antici-
pated for patients without radiation therapy. Explanations
might include greater severity of native coronary artery dis-
ease and poor distal arterial run-off caused by radiation dam-
age. Radiation might also cause intimal injury to the ITA,
although in a recent report irradiated ITAs had similar
amounts of fibrosis on histomorphologic examination
when compared with nonirradiated ITAs.9 Another impor-
tant factor in understanding overall graft patency is that pa-
tients underwent symptom-directed angiography rather than
routine catheterization. Buxton and associates18 have previ-
ously shown that symptom-directed graft failure rates might
be as much as double those of an asymptomatic group (17%
vs 9% in the ITA at 5 years, P ¼ .002). There are few data1170 The Journal of Thoracic and Cardiovascular Supublished on graft patency in patients with prior mediastinal
radiation because prior studies used both clinical and nonin-
vasive follow-up.3,4
Age-adjusted survival was superior among patients who
had an ITA graft to the LAD when compared with those
who had a venous graft, although this was not statistically
significant. This is likely highly susceptible to selection
bias because in most cases the ITA was considered for use
unless it appeared fibrotic or had poor flow. In addition, it
is also possible that surgeons have a preference for placing
ITA grafts in healthier patients. Our study reports a some-
what lower survival than our previously reported 5-year sur-
vival of 73% for patients undergoing CABG after previous
mediastinal radiation.16 In the current series, however, we
included patients who had concomitant valvular heart dis-
ease that might indicate a poorer prognosis.19
Finally, it must be acknowledged that our study might
simply be underpowered to detect a difference between the
patency of an ITA or venous conduit. In addition, we did
not have adequate patient numbers to assess the effect of
the radial artery in this cohort.
CONCLUSION
Irradiated ITA grafts had similar patency rates to venous
or radial arterial conduits. Either ITA grafts or venous con-
duits can be used in patients who have received previous
mediastinal radiation. However, when patent, these data
suggest the ITA graft remains the conduit choice for grafting
to the LAD in patients with prior mediastinal radiation
therapy.
References
1. Schultz-Hector S, Trott KR. Radiation-induced cardiovascular diseases: is the
epidemiologic evidence compatible with the radiobiologic data? Int J Radiat
Oncol Biol Phys. 2007;67:10-8.
2. Baker DG, Krochak RJ. The response of the microvascular system to radiation:
a review. Cancer Invest. 1989;7:287-94.
3. Nasso G, Canosa C, De Filippo M, Mondugno P, Anselmi A, Gaudino M, et al.
Thoracic radiation therapy and suitability of internal thoracic arteries for myocar-
dial revascularization. Chest. 2005;128:1587-92.
4. Van Son JA, Noyez L, van Asten WN. Use of internal mammary artery in myo-
cardial revascularization after mediastinal irradiation. J Thorac Cardiovasc Surg.
1992;104:1539-44.
5. Gharagozloo F, Clements IP, Mullany CJ. Use of the internal mammary artery for
myocardial revascularization in a patient with radiation-induced coronary artery
disease. Mayo Clin Proc. 1992;67:1081-4.
6. Reber D, Birnbaum DE, Tollenaere P. Heart diseases following mediastinal
irradiation: surgical management. Eur J Cardiothorac Surg. 2005;9:202-5.
7. Fuzellier JF, Mauran P, Metz D. Radiation-inducted bilateral coronary ostial
stenosis in a 17-year-old patient. J Card Surg. 2006;21:600-2.
8. Gansera B, Haschemi A, Angelis I, Eichinger W, Breuer M, Keiditsch E, et al.
Cardiac surgery in patients with previous carcinoma of the breast and mediastinal
irradiation: is the internal thoracic artery graft obsolete? Thorac Cardiovasc Surg.
1999;47:376-80.
9. Gansera B, Schmidtler F, Angelis I, Botzenhardt F, Schuster T, Kiask T, et al.
Quality of internal thoracic artery grafts after mediastinal irradiation. Ann Thorac
Surg. 2007;84:1479-84.
10. Schulman HE, Korr KS, Myers TJ. Left internal thoracic artery graft occlusion
following mediastinal radiation therapy. Chest. 1994;105:1881-2.
11. Hanet C, Marchand E, Keyex A. Left internal mammary artery occlusion after
mastectomy and radiotherapy. Am J Cardiol. 1990;65:1044-5.rgery c November 2008
Brown et al Surgery for Acquired Cardiovascular Disease
A
C
D12. Renner S, Massel D, Moon BC. Mediastinal irradiation: a risk factor for
atherosclerosis of the internal thoracic arteries. Can J Cardiol. 1999;15:
597-600.
13. Hicks GL Jr. Coronary artery operation in radiation-associated atherosclerosis:
long-term follow-up. Ann Thorac Surg. 1992;53:670-4.
14. Tatoulis J, Buxton BF, Fuller JA. Patencies of 2127 arterial to coronary conduits
over 15 years. Ann Thorac Surg. 2004;77:93-101.
15. Hayward PA, Buxton BF. Contemporary coronary graft patency: 5-year observa-
tional data from a randomized trial of conduits. Ann Thorac Surg. 2007;84:795-9.
16. Handa N, McGregor CGA, Danielson GK, Orszulak TA, Mullany CJ,
Daly RC, et al. Coronary artery bypass grafting in patients with previousThe Journal of Thoracic and Camediastinal radiation therapy. J Thorac Cardiovasc Surg. 1999;117:
1136-43.
17. Loop FD, Lytle BW, Cosgrove DM, Stewart RW, Goormaster M, Williams GW,
et al. Influence of the internal-mammary-artery graft on 10-year survival and other
cardiac events. N Engl J Med. 1986;314:1-6.
18. Buxton BF, Durairaj M, Hare DL, Gordon I, Moten S, Orford V, et al. Do angio-
graphic results from symptom-directed studies reflect true graft patency? Ann
Thorac Surg. 2005;80:896-901.
19. Handa N, McGregor CG, Danielson GK, Daly RC, Dearani JA, Mullany CJ, et al.
Valvular heart operation in patients with previous mediastinal radiation therapy.
Ann Thorac Surg. 2001;71:1880-4.rdiovascular Surgery c Volume 136, Number 5 1171
